as on March 10, 2026 at 9:31 pm IST
Day's Low
Day's High
1.43%
Downside
2.15%
Upside
52 Week's Low
52 Week's High
51.82%
Downside
6.56%
Upside
as on March 10, 2026 at 4:01 pm IST
Market Cap
₹1,140.93 Cr
Return on Equity (ROE)
0.64
PE Ratio (TTM)
3.84
Return on capital employed (ROCE)
1.09
Industry PE ratio
42.02
Beta (LTM)
0.86
P/B Ratio
0.53
Dividend Yield
0PEG Ratio
-0.08
Quarterly Earnings Growth YOY
-273.09
EPS (TTM)
36.44
Sector
Pharmaceuticals
Book Value
159.86
Technical Analysis
Bullish
View Technical Analysis
as on March 10, 2026 at 4:01 pm IST
Ind-Swift Laboratories in the last 5 years
Lowest (-1795.00x)
December 8, 2022
Today (3.84x)
March 9, 2026
Industry (42.02x)
March 9, 2026
Highest (64.97x)
July 19, 2021
Today’s Price to Earnings Ratio: 3.84x
Compare market cap, revenue, PE, and other key metrics of Ind-Swift Laboratories with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 1,140.93 | 15.6% | 0.52 | 250 | 561 | |
| NA | 2,481.09 | 3.75% | 0.68 | 3 | 2,711 | |
| NA | 59.84 | -8.37% | 0.00 | 4 | 61 | |
| BUY | 27,637.89 | -6.53% | 0.53 | 698 | 5,616 | |
| NA | 32.35 | 0.64% | 0.63 | 5 | 96 |
Search interest for Ind-Swift Laboratories Ltd Stock has increased by 80% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:80% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Ind-Swift Laboratories.
Ind-Swift Laboratories Ltd’s net profit jumped 273.77% since last year same period to ₹9.54Cr in the Q3 2025-2026. On a quarterly growth basis, Ind-Swift Laboratories Ltd has generated 19.4% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2011, Ind-Swift Laboratories Ltd has declared dividend of ₹1.00 per share on 25 May 2011 - translating a dividend yield of 1.43%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 167.32 Cr → 178.43 Cr (in ₹), with an average increase of 3.2% per quarter
Profit Spike
![]()
Netprofit is up for the last 2 quarters, 7.99 Cr → 9.54 Cr (in ₹), with an average increase of 16.3% per quarter
Retail Holding Up
![]()
Retail Investor have increased holdings from 45.02% to 45.50% in Dec 2025 quarter
Best in 1 Year
![]()
In the last 1 year, INDSWFTLAB has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Price Rise
![]()
In the last 7 days, INDSWFTLAB stock has moved up by 10.8%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 39.50% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 189.4% return, outperforming this stock by 68.0%
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 14.80% to 14.33% in Dec 2025 quarter
| Organisation | Ind-Swift Laboratories Ltd |
| Headquarters | Chandigarh |
| Industry | Pharmaceuticals |
| CEO | N R Munjal |
| E-voting on shares | Click here to vote |
Ind-Swift Laboratories share price today stands at ₹142.63 as on at the close of the market. Ind-Swift Laboratories share today touched a day high of ₹145.7 and a low of ₹140.59.
Ind-Swift Laboratories touched a 52 week high of ₹151.98 and a 52 week low of ₹68.72. Ind-Swift Laboratories share price today i.e. is closed at ₹142.63, which is -6.15% down from its 52 week high and 107.55% up from its 52 week low.
Ind-Swift Laboratories market capitalisation is ₹1,140.93 Cr as on .
To buy Ind-Swift Laboratories shares, you need to follow these steps:
Ind-Swift Laboratories trading volume is 4.01L as on . This means that 4.01L shares of Ind-Swift Laboratories were bought and sold on the stock market during today's trading session.